Levothyroxine Sodium
Rank #44 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$435.3M
Total Cost
20,209,418
Total Claims
$435.3M
Total Cost
167,050
Prescribers
$22
Cost per Claim
4,995,485
Beneficiaries
46,809,828
30-Day Fills
$2,606
Avg Cost/Provider
121
Avg Claims/Provider
Share of Medicare Part D Spending
0.16%
of total Medicare Part D spending
$435.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $435.3M total
🔎 Data Overview
Ranked #44 out of 500 drugs tracked by total cost. Levothyroxine Sodium represents a significant portion of Medicare drug spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Levothyroxine Sodium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Carlos Martinez Rivera | Endocrinology | Mayaguez, PR | 4,705 | $355K |
| 2 | Manuel Alegre-Hernandez | Endocrinology | San Juan, PR | 2,504 | $308K |
| 3 | Denise Caro | Endocrinology | Mayaguez, PR | 2,998 | $302K |
| 4 | Cesar Trabanco | Endocrinology | Ponce, PR | 4,783 | $295K |
| 5 | Jorge Martinez | Endocrinology | Bayamon, PR | 1,992 | $222K |
| 6 | Altagracia Alcantara Gonzalez | Endocrinology | Bayamon, PR | 3,289 | $219K |
| 7 | Ivan Laboy-Ortiz | Endocrinology | Caguas, PR | 3,781 | $215K |
| 8 | Sheila Mercado | Endocrinology | Manati, PR | 3,129 | $180K |
| 9 | Rose Roman Torres | Endocrinology | Mayaguez, PR | 1,682 | $172K |
| 10 | Naomi Collazo Gutierrez | Endocrinology | Manati, PR | 1,742 | $169K |
| 11 | Jose Montalvo-Figueroa | Endocrinology | Ponce, PR | 3,059 | $168K |
| 12 | Suzette Toro | Endocrinology | San German, PR | 2,756 | $156K |
| 13 | Dalitza Alvarez Valentin | Endocrinology | San Juan, PR | 1,473 | $155K |
| 14 | Rafael Gonzalez-Rosario | Internal Medicine | Rio Piedras, PR | 2,604 | $152K |
| 15 | Mario Maldonado Ramirez | Internal Medicine | Corozal, PR | 1,187 | $150K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 41 | Acalabrutinib Maleate (Calquence) | $457.0M | 31,890 |
| 42 | Atorvastatin Calcium (Atorvastatin Calcium) | $444.6M | 30,263,929 |
| 43 | Osimertinib Mesylate (Tagrisso) | $436.5M | 25,273 |
| 44 | Levothyroxine Sodium (Levothyroxine Sodium) | $435.3M | 20,209,418 |
| 45 | Deutetrabenazine (Austedo) | $404.1M | 60,532 |
| 46 | Linagliptin (Tradjenta) | $403.8M | 519,439 |
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology